News GlaxoSmithKline Pharmaceuticals Limited

Stocks

GLAXO

INE159A01016

Pharmaceuticals

Market Closed - Bombay S.E. 03:32:25 16/09/2026 pm IST			5-day change	1st Jan Change
2,853.85 ^INR	+1.41%		-1.12%	+15.50%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

All News

Mentions Relevance

03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
03/08	Glaxosmithkline Pharmaceuticals Limited Announces Management Changes	CI
09/07	Delhi High Court Declares GSK’s ‘CALPOL’ A Well-Known Trademark	AQ
29/05	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
13/05	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT
13/05	GlaxoSmithKline Pharmaceuticals March-quarter consol profit 2.78 billion rupees	RE
13/05	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
13/05	GlaxoSmithKline Pharmaceuticals Limited announces Annual dividend, payable on July 30, 2026	CI
21/04	Glaxosmithkline Pharmaceuticals Limited Announces Appointment of Vinay Subramanian as Commercial Head ? Oncology and Senior Management Personnel, Effective April 20, 2026	CI
31/03	GlaxoSmithKline Pharmaceuticals receives TDS demand liability of 20.1 million rupees	RE
24/03	GlaxoSmithKline Pharmaceuticals Ltd receives final order with tax demand liability of 232.1 mln rupees for AY 2023-24	RE
16/03	GlaxoSmithKline Pharmaceuticals Ltd says Juby Chandy resigns as whole-time director and CFO	RE
02/03	GlaxoSmithKline Pharmaceuticals Names CFO	MT
02/03	GlaxoSmithKline Pharmaceuticals says Ronojit Biswas appointed as whole-time director & CFO	RE
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Chief Financial Officer Changes	CI
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes	CI
23/02	GlaxoSmithKline Pharmaceuticals gets order with total tax demand of 37.9 million rupees including tax, penalty	RE
10/02	GlaxoSmithKline Pharmaceuticals Limited - Shareholder/Analyst Call
09/02	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
09/02	GlaxoSmithKline Pharmaceuticals Ltd Dec-quarter consol profit 2.96 billion rupees	RE
31/12	GlaxoSmithKline Pharmaceuticals gets tax demand of 85.7 million rupees	RE
22/12	GlaxoSmithKline Pharmaceuticals Ltd receives tax demand order of 9 million rupees	RE
06/11	GlaxoSmithKline Pharma Q2 consol profit 2.57 billion rupees	RE
29/25/29	GlaxoSmithKline Pharmaceuticals Limited Announces Resumption Of Sukanya Choudhury As Executive Vice President - Regulatory Affairs	CI
08/25/08	Glaxosmithkline pharmaceuticals gets tax demand of total 18.1 million rupees	RE